JDD Article Highlight
Platelet-rich concentrates (PRCs) have become popular in dermatology for a variety of treatments, but recent reports link their use to blood-borne infections like HIV and hepatitis. While the procedure is generally safe, the JDD article titled “Minimizing Medical Error-Related Adverse Events With Platelet-Rich Plasma: A Protocolized Approach to Safety” highlights the need for rigorous safety protocols to reduce the risk of such complications. Ensuring patient safety through standardized systems and error-reduction measures is crucial as PRC treatments continue to grow in dermatologic practice.
